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RELATIONSHIP OF CARBON MONOXIDE PULMONARY
DIFFUSING CAPACITY TO POSTOPERATIVE
CARDIOPULMONARY COMPLICATIONS IN PATIENTS
UNDERGOING PNEUMONECTOMY
Jeng-Shing Wang
Respiratory Medicine Section, Vancouver General Hospital and
University of British Columbia, Vancouver, British Columbia, Canada.
This retrospective analytic study evaluated whether abnormal diffusing capacity for carbon monoxide
(DLCO) is a predictor of postoperative morbidity and mortality in patients undergoing pneumonectomy
for lung cancer. The medical records of patients undergoing pneumonectomy at Vancouver General
Hospital between January 1992 and December 1997 were reviewed. Postoperative complications occurring
within 30 days of resection were classified into mortality, and cardiovascular, pulmonary, and technical
complications. A total of 151 pneumonectomy cases were reviewed. There were 100 men (66%) and 51
women (34%) with a mean age of 61 years. Complications occurred in 73 patients (48%), including mortality
in eight (5%), cardiovascular morbidity in 50 (33%), pulmonary morbidity in 30 (20%), and technical
morbidity in 22 (15%). Arrhythmia (21%) and pulmonary edema (13%) were the two major cardiovascular
complications. Patients with complications had a greater smoking history, a longer hospital stay, a lower
forced expiratory volume in 1 second (FEV1), a lower FEV1/forced vital capacity (FVC) ratio, a lower DLCO,
and a lower DLCO/alveolar volume (VA) ratio than patients without complications. A DLCO of 70%
predicted was the best functional predictor of postoperative complications, with a complication rate of
94% in patients with a DLCO of less than 70% predicted compared with 27% in patients with a DLCO
of at least 70% predicted (sensitivity, 62%; specificity, 96%). However, technical morbidity was not related
to preoperative lung function variables, including DLCO. Patients with a DLCO of at least 70% predicted
had a low postpneumonectomy complication rate. Although cardiac arrhythmia was the major cause of
morbidity, pulmonary edema was the major cause of mortality.
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Lung cancer is the most common cause of death due to
cancer in men, and has become the most common cancer in
women. The prognosis in untreated cases is poor; at present,
the curative treatment for non-small-cell lung cancer without
metastasis is lung resection. The removal of lung
parenchyma from patients, who are usually smokers and
have chronic obstructive pulmonary disease [1] and may
have compromised cardiovascular or pulmonary status,
may lead to cardiopulmonary complications or death. The
functional loss resulting from lung resection varies with the
extent of resection, the relative function of the tissue removed
compared with that of the remaining lung tissue, and the
degree of functional impairment prior to surgery. Currently,
about 30% of patients undergoing lung resection develop
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cardiopulmonary complications, with a 30 day mortality
varying between 0.6% and 5% [2–4] depending on the
extent of lung resection. The mortality in one study was
6.8% following pneumonectomy and 3.9% following
lobectomy [2], while that in another study was 5.7% after
pneumonectomy, 4.4% after bilobectomy, and 1.4% after
lesser resections [4].
Many parameters have been used to assess the risk of
postoperative outcome, but it is not clear which preoperative
pulmonary function tests are the best predictors of
postoperative complications. Preoperative pulmonary
function testing usually includes spirometry, lung volumes,
diffusing capacity, oximetry, and arterial blood gases, and
may include, in selected cases, radionuclide lung scanning,
exercise testing, invasive pulmonary hemodynamic
measurements, and risk stratification analysis. The single
breath diffusing capacity of the lung for carbon monoxide
(DLCO) has recently been shown to be an independent
predictor of postoperative outcome, including mortality and
postoperative complications [5–8]. Patients with low DLCO
(= 60% predicted for pneumonectomy or bilobectomy, = 50%
predicted for lobectomy) underwent major pulmonary
resection with an increased respiratory complication rate [9].
A low preoperative DLCO may identify those patients who
have emphysema and a reduced pulmonary capillary bed.
They may be prone to postoperative cardiopulmonary
complications because of reductions in the pulmonary
capillary bed and reduced gas capacity for exchange,
especially after pneumonectomy. The purpose of this
retrospective study was to evaluate whether abnormal
DLCO is specifically useful in predicting postoperative
morbidity and mortality following pneumonectomy.
MATERIALS AND METHODS
The study was approved by the University of British
Columbia Ethics Committee. We reviewed the hospital
records of all patients who had undergone pneumonectomy
for lung cancer at Vancouver General Hospital between
January 1992 and December 1997; we excluded patients
who had received radiation treatment or chemotherapy
prior to surgery. A total of 151 charts were reviewed to
determine whether preoperative lung function data
predicted postoperative cardiopulmonary complications.
Diagnosis and staging were based on one or more of the
following: chest roentgenography and computed
tomography (CT) scan, sputum cytology, bronchoscopy
with bronchial brushing and/or biopsy, and biopsy or
cytology of the lung lesion. The final diagnosis was based
on the pathology of the resected lung. Mediastinal
involvement was generally excluded by mediastinoscopy
or CT scan of the chest, and metastasis by CT scan of the
brain, liver and bone if clinically warranted.
From the medical records, we obtained general data
including age, sex, height, weight, smoking habit, and the
presence of diabetes, prior thoracic operation, chronic
obstructive pulmonary disease, and heart disease (including
hypertension, old myocardial infarction, and New York
Heart Association class). We also noted the duration of
hospitalization and of the postoperative period, the year of
surgery, the operation site and position used for surgery,
and if pericardial dissection was performed. Laboratory
data including blood hemoglobin, serum albumin,
creatinine, and glutamine oxaloacetic transaminase (GOT)
were recorded. We reviewed cardiac evaluation (electro-
cardiogram, echocardiogram, and cardiac stress test),
radionuclide lung ventilation/perfusion scan, and radiology
findings including chest roentgenography and chest CT
scan. Lung function data, including forced expiratory
volume in 1 second (FEV1), forced vital capacity (FVC),
DLCO, and DLCO/alveolar volume (DLCO/VA), were
expressed as % predicted value. We used the prediction
equations of Crapo et al for spirometry and lung volumes [10,
11], and those of Miller et al for nonsmokers for DLCO [12].
Spirometry was performed using a computerized dry
rolling seal spirometer (either Model “Transfer Test USA”,
PK Morgan, Chatham, Kent, UK, or Model No. 922,
Sensormedics, Anaheim, CA, USA) according to American
Thoracic Society (ATS) criteria [13]. The highest values of
FEV1 and FVC were taken from the two best tests that
agreed with each other to within 5%. Lung volumes were
determined using the helium dilution technique on the
Morgan equipment. Each patient rebreathed a 10% helium
mixture in a closed circuit until equilibrium was reached,
and the helium concentration was continuously monitored
using a helium analyzer. DLCO was determined using the
single breath technique [14] with an automated valve and
timing device and a bag in a box system with the Morgan
equipment, as previously described [15,16]. The subject
inhaled a volume of test gas containing 10% helium, 0.3%
carbon monoxide, 21% oxygen, and the balance nitrogen. A
breath-holding time of about 10 seconds was used and
determined by the Jones-Meade method [17]. The dead
space washout and alveolar sample volumes were set at
900 mL. All assessments of DLCO conformed to ATS
standards [18]. The mean of two DLCO measurements
within 5% of each other was taken to be the measured
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DLCO, and a maximum of four DLCO maneuvers, each
separated by at least 4 minutes, were performed.
Complications occurring within 30 days after resection
were considered to be postoperative complications.
Complications were classified into mortality, and
cardiovascular, pulmonary, and technical morbidity.
Cardiovascular morbidity included myocardial infarction,
congestive heart failure, pulmonary edema, shock,
arrhythmia, and cerebrovascular accident. Pulmonary
morbidity included ventilatory support greater than
48 hours, re-intubation, pulmonary embolism, pneumonia,
atelectasis, and respiratory insufficiency (PaCO2 > 45 mmHg
or PaO2 < 55 mmHg, without supplemental oxygen). Tech-
nical morbidity included bronchopleural fistula, recurrent
laryngeal nerve injury, wound infection, empyema,
hematoma, and miscellaneous morbidities such as
mediastinitis, pneumomediastinum, and bleeding.
Data analysis was done with Microsoft Excel™ 97
(Microsoft, Santa Rosa, CA, USA) and SPSS™ 8.0 (SPSS,
Chicago, IL, USA). We determined the means and standard
deviations (SDs) for the different variables in patients with
and without complications. Comparisons between different
groups for continuous variables were made using the two-
tailed Student’s t test. The Chi-squared test was used for
categorical variables. Multiple variable analysis using
stepwise logistic regression [19] was performed to
investigate the relative usefulness of the combination of
variables for the prediction of postoperative complications.
A p value of less than 0.05 was considered statistically
significant. Receiver operating characteristic (ROC) curves
[20] and Fisher’s exact test [21] were used to define the best
cut-off limits of the different variables in relation to
postoperative complications, and sensitivity, specificity,
positive predictive value, and negative predictive value for
each variable were determined [20]. The area under the
ROC curve (AURC) was estimated using the following
algorithm: AURC between 2 successive points = mean
sensitivity × difference in (1 – specificity).
The total AURC is the sum of successive individual
areas. The relative risk and risk difference for postoperative
complications, obtained using a given cut-off limit for a
preoperative variable, were calculated as A(C+D)/C(A+B)
and A/(A+B) – C/(C+D) (Table 1).
RESULTS
The 151 pneumonectomy patients had a mean age of 61 ± 10
(mean ±  SD) years; 100 were men (66%) and 51 women
(34%). A total of 136 patients (90%) were smokers or ex-
smokers, with a mean smoking history of 46 pack-years; 15
patients had never smoked. The mean duration of
hospitalization was 14 ± 7 days, with a mean postoperative
stay of 9 ± 3 days. Most patients (139, 92%) had primary lung
cancer. The most common type was squamous carcinoma
(73 patients, 48%), followed by adenocarcinoma (46 patients,
30%), and poorly differentiated carcinoma (13 patients, 9%).
Four patients had adenosquamous carcinoma, and in three
patients, the final pathology of the resected lung showed
small-cell carcinoma (the preoperative diagnosis in all three
cases was non-small-cell carcinoma). There were 12 cases of
metastatic cancer of various types.
Lung function tests showed an FEV1 (mean ±  SD) of
2.39 ± 0.68 L, FEV1 % predicted of 78 ± 18%, FVC of 3.53 ±
0.90 L, FVC % predicted of 90 ± 18%, FEV1/FVC of 68 ± 11%,
residual volume (RV)/total lung capacity (TLC) of 35 ± 8%,
DLCO of 20.08 ± 5.78 mL/min/mmHg, DLCO % predicted
of 80 ± 20%, DLCO/VA of 3.77 ± 0.97 mL/min/mmHg/L,
and DLCO/VA % predicted of 87 ± 22%.
Complications occurred in 73 patients (48%), and
included mortality (5%), cardiovascular morbidity (33%),
pulmonary morbidity (20%), and technical morbidity (15%)
(Table 2). The causes of death were pulmonary edema in six
patients, cerebrovascular accident in one, and acute
myocardial infarction in one. Arrhythmia and pulmonary
edema were the two major causes of cardiovascular
morbidity, occurring in 21% and 13%, respectively, of all
patients. Arrhythmias included atrial fibrillation in 28
patients, atrial flutter in two, frequent ventricular premature
contractions in one, and ventricular bigeminy in one.
Pneumonia was the major cause of pulmonary morbidity
(11%), and recurrent laryngeal nerve injury was the most
common cause of technical morbidity (3%). Miscellaneous
technical morbidity included mediastinitis (1 patient),
pneumomediastinum (1), bleeding (1), septicemia (1), renal
failure (1), enteritis (1), benign prostatic hypertrophy (1),
ischemic heart disease (1), chest wall infection (1), and
pleurisy (1).
Patients with complications had a significantly greater
smoking history and a longer hospital stay than patients
without complications, and also had significantly lower
FEV1 % predicted, FEV1/FVC, DLCO % predicted, and
DLCO/VA % predicted than those without complications
(Table 3). There was no significant difference between the
patients with technical complications and patients without
technical complications for any preoperative variable,
including hypertension, previous myocardial infarction,
New York Heart Association class, or abnormal
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electrocardiogram, echocardiogram, or cardiac stress test.
Table 4 compares preoperative variables between the
mortality cases and the remaining patients. There were
significant differences in age and FEV1/FVC between the
two groups. Patients who died were significantly older by
a mean of 9 years. The unexpectedly higher FEV1/FVC in
the mortality group might have been due to a slightly lower
FVC in this group, leading to a higher FEV1/FVC ratio. No
other preoperative variable (including hypertension,
previous myocardial infarction, New York Heart Association
class, and abnormal electrocardiogram, echocardiogram,
or cardiac stress test) was significantly different in the
mortality cases and the remaining patients.
Using multiple variable stepwise logistic regression, no
model was found that, after combining different variables,
significantly improved the prediction of overall com-
plications, mortality, cardiovascular morbidity, and
pulmonary morbidity as compared with the single variable
analysis. The best predictor was DLCO % predicted for
overall complications (p < 0.001), cardiovascular morbidity
(p < 0.001), and pulmonary morbidity (p < 0.001). For
mortality, the only predictor was age (p < 0.05). The incidence
of overall complications, cardiac morbidity, pulmonary
morbidity, technical morbidity, and mortality were
calculated for six intervals of DLCO % predicted (< 40, < 50,
< 60, < 70, < 80, and ≥ 80%), which was the best predictive
preoperative variable (Figure 1). Overall complications,
cardiac morbidity, and pulmonary morbidity were related
to DLCO % predicted, but technical morbidity and mortality
were not. The incidence of overall complications, cardiac
morbidity, pulmonary morbidity, technical morbidity, and
mortality was calculated for six intervals of age (≤ 55, > 55,
> 60, > 65, > 70, and > 75 years) (Figure 2). There was no
mortality among patients aged 55 years or less, while
increased mortality was observed among patients more
than 70 years in age.
To evaluate the level of preoperative variables that
correlated with complications, the incidence of
complications was calculated for six intervals (< 40, < 50,
< 60, < 70, < 80, and ≥ 80%) for DLCO % predicted,
DLCO/VA % predicted, FEV1 % predicted, and FEV1/FVC.
The ROC curves of these four variables for overall
complications, cardiovascular morbidity, and pulmonary
morbidity were determined and the AURC was calculated.
The largest AURC was 0.84, calculated from the ROC curve
of DLCO % predicted for overall complications (Figure 3),
confirming that DLCO % predicted was the best predictor.
Furthermore, the incidence of mortality was calculated for
six intervals for age (≤ 55, > 55, > 60, > 65, > 70, and > 75
years), the ROC curve of age for mortality was determined,
and the AURC was calculated (Figure 4). The AURC was
0.77, confirming that age was the best predictor for mortality.
The best cut-off limit was defined by the point closest to
the left upper corner, and it was 70% in the ROC curve of
DLCO % predicted for overall complications (p < 0.001)
(Figure 3). Forty-five of 73 patients with overall
complications had a DLCO of less than 70% predicted
(sensitivity, 62%), and 75 of 78 patients without overall
complications had a DLCO of at least 70% predicted
(specificity, 96%). This gave a positive predictive value of
Table 1. Definition of symbols used to calculate different
cut-off limits from Fisher’s exact test
Complications No complications
< Cut-off limits A B
≥ Cut-off limits C D
Table 2. Prevalence of postoperative complications
following pneumonectomy, n = 151
n (%)
Overall complications 73 (48)
Mortality 8 (5)
Cardiovascular morbidity* 50 (33)
   Myocardial infarction 3 (2)
   Congestive heart failure 7 (5)
   Pulmonary edema 20 (13)
   Shock 3 (2)
   Arrhythmia 31 (21)
   Cerebrovascular accident 4 (3)
Pulmonary morbidity* 30 (20)
   Ventilatory support > 48 hr 7 (5)
   Re-intubation 7 (5)
   Pulmonary embolism 2 (1)
   Pneumonia 17 (11)
   Lobar collapse 11 (7)
   Respiratory insufficiency 10 (7)
Technical morbidity* 22 (15)
   Bronchopleural fistula 2 (1)
   Recurrent laryngeal nerve injury 5 (3)
   Wound infection 4 (3)
   Hematoma 2 (1)
   Empyema 2 (1)
   Miscellaneous 10 (7)
* More than one type of morbidity may be found in any one patient.
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77%, a negative predictive value of 81%, a relative risk of
3.4 and a risk difference of 67% (p < 0.001, Fisher’s exact
test). For age (Figure 4),  70 years was the best cut-off
limit. Five of the eight mortality cases were over 70 years
old (sensitivity, 63%), and 119 of 143 patients without
mortality were at or below this cut-off (specificity, 83%).
Table 3. Preoperative variables examined in relation to pneumonectomy
No complications (n = 78) Complications (n = 73) p
Age (yr) 61  ± 11 62  ± 10 NS
Height (cm) 169 ± 10 169 ± 9 NS
Weight (kg) 74 ± 14 72 ± 14 NS
Smoking (pack-years) 40 ± 19 (n = 68) 53  ± 27 (n = 68)  < 0.01
Hemoglobin (g/L) 130  ± 16 127 ± 18 NS
Albumin (g/L) 38 ± 5 (n = 46) 37 ± 7 (n = 51) NS
Creatinine (µmol/L) 82 ± 16 83 ± 20 NS
GOT (U/L) 22 ± 6 (n = 62) 24 ± 13 (n = 62) NS
Hospital stay (d) 13 ± 6 16 ± 8  < 0.01
Postoperative stay (d) 9 ± 2 9 ± 4 NS
FEV1 (L) 2.52 ± 0.69 2.22 ± 0.63 < 0.01
FVC (L) 3.60 ± 0.88 3.42 ± 0.89 NS
FEV1 % predicted 83 ± 17 74 ± 17 < 0.001
FVC % predicted 93 ± 17 88 ± 19 NS
FEV1/FVC (%) 70 ± 10 66 ± 12 < 0.01
RV/TLC (%) 34 ±  7 36 ± 9 NS
DLCO (mL/min/mmHg) 22.56 ± 4.98 17.42 ± 5.41 < 0.001
DLCO % predicted 90 ± 16 69 ± 18 < 0.001
DLCO/VA (mL/min/mmHg/L) 4.12 ± 0.73 3.40 ± 1.06 < 0.001
DLCO/VA % predicted 96 ± 16 79 ± 23 < 0.001
NS = not significant; GOT = glutamine oxaloacetic transaminase; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity;
RV = residual volume; TLC = total lung capacity; DLCO = diffusing capacity for carbon monoxide; VA = alveolar volume.
Table 4. Comparison of variables between patients with mortality or without mortality
Mortality (n = 8) No mortality (n = 143) p
Age (yr) 70 ± 7 61 ± 10 < 0.01
Height (cm) 168 ± 5 169 ± 10 NS
Weight (kg) 72 ± 11 73 ± 14 NS
Smoking (pack-years) 58 ± 42 (n = 7) 45 ± 23 (n = 129) NS
Hemoglobin (g/L) 126 ± 23 128 ± 16 NS
Albumin (g/L) 31 ± 9 (n = 7) 38 ± 5 (n = 90) NS
Creatinine (µmol/L) 80 ± 21 83 ± 18 NS
GOT (U/L) 38 ± 33 (n = 7) 22 ± 6 (n = 117) NS
Hospital stay (d) 20 ± 12 14 ± 7 NS
Postoperative stay (d) 8 ± 4 9 ± 3 NS
FEV1 (L) 2.29 ± 0.59 2.40 ± 0.68 NS
FVC (L) 3.20 ± 0.94 3.55 ± 0.90 NS
FEV1 % predicted 78 ± 16 78 ± 18 NS
FVC % predicted 83 ± 18 91 ± 17 NS
FEV1/FVC (%) 74 ± 6 68 ± 11 < 0.05
RV/TLC (%) 36 ± 6 35 ± 9 NS
DLCO (mL/min/mmHg) 18.58 ± 6.27 20.16 ± 5.77 NS
DLCO % predicted 76 ± 20 80 ± 20 NS
DLCO/VA (mL/min/mmHg/L) 3.98 ± 1.00 3.76 ± 0.97 NS
DLCO/VA % predicted 95 ± 23 87 ± 22 NS
NS = not significant; GOT = glutamine oxaloacetic transaminase; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity;
RV = residual volume; TLC = total lung capacity; DLCO = diffusing capacity for carbon monoxide; VA = alveolar volume.
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This gave a positive predictive value of 17%, a negative
predictive value of 98%, a relative risk of 7.0 and a
risk difference of 15% (p < 0.01, Fisher’s exact test).
Postoperative complications were compared using these
preoperative variables. Again, the best predictor for
complications was DLCO % predicted and the best
predictor for mortality was age.
DISCUSSION
Our study showed that patients with overall complications
had a greater smoking history, longer hospital stay, lower
FEV1 % predicted, lower FEV1/FVC, lower DLCO %
predicted, and lower DLCO/VA % predicted than patients
without overall complications (Table 3). Both DLCO and
spirometry data were useful in discriminating postoperative
complications. Further analyses using logistic regression
models and ROC curves with AURC determinations (Figure
3) showed that DLCO % predicted was the best predictor
for overall complications, followed, in decreasing order, by
DLCO/VA % predicted, FEV1 % predicted, and FEV1/FVC.
The same analysis showed that these variables predicted
overall complications best, followed, in decreasing order,
by cardiovascular morbidity, pulmonary morbidity, and
mortality, as shown for DLCO % predicted in Figure 1.
Our results indicated that diffusing capacity was a
strong predictor of risk of complications, including
cardiovascular and pulmonary morbidity,  after
pneumonectomy. The strong correlation between diffusing
capacity and complications is probably due to the
contribution of a reduced pulmonary capillary bed and
alveolar capillary membrane to cardiopulmonary
complications. Our results suggested that a DLCO of at
least 70% predicted would be associated with a low
postpneumonectomy complication rate. DLCO/VA was
not as good a predictor as DLCO in relation to postoperative
complications. A normal DLCO/VA can be misleading,
implying that a low DLCO with a reduced single VA and a
normal DLCO/VA reflect a normal pulmonary capillary
bed [22].
In patients with technical complications, none of the
variables used for preoperative evaluation were significantly
different from those in patients without technical
complications. This finding indicates that technical
morbidity was not related to patients’ lung function,
including DLCO (Figure 1), but was due to other factors
such as surgical technique, anesthetic technique, nursing
care, and perioperative care. The lack of relation between
diffusing capacity and technical morbidity indicates the
specific value of a low diffusing capacity in predicting
cardiopulmonary complications following pneumo-
nectomy.
The mortality group was significantly different from the
group without mortality, being older by a mean of about
9 years, but did not have lower lung function values (Table
Figure 1. Incidence of mortality, technical morbidity, pulmonary
morbidity, cardiovascular morbidity, and overall complications in relation
to diffusing capacity for carbon monoxide (DLCO) % predicted. Mortality
and technical morbidity were not related to DLCO % predicted.
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4). Analyses using logistic regression models and ROC
curves with AURC determinations (Figure 4) showed that
age was the best predictor for mortality. Greater age may
have increased the risk of underlying heart disease
predisposing to mortality, since pulmonary edema was the
major cause of mortality. Our results suggested that an age
of 70 years or less would be associated with a relatively low
postpneumonectomy mortality rate. Mortality was
predictable by age (Figure 2), but not by DLCO, which was
the  bes t  preopera t ive  var iab le  predic t ive  o f
cardiopulmonary complications (Figure 1). Our patients
with low DLCO usually had well-preserved spirometry
values (70 ± 11% predicted FEV1 and 84 ± 23% predicted
FVC in patients with DLCO < 60% predicted). Modern
surgical, anesthetic, and critical care techniques used
routinely in the perioperative period may have reduced the
mortality rate in patients with poor lung function [9] and
resulted in the lack of relationship between preoperative
variables and mortality [23]. In other studies, there was
disagreement about the relationship of a low DLCO to
postoperative mortality. Four studies showed a relationship
between impaired DLCO and postoperative mortality [5–
8], while two did not show such a relationship [9,23]. This
difference may be due to the different patient populations
studied, the differences in extent of resection, and possibly
the differences in surgical, anesthetic, and critical care
techniques used in the different centers.
Since the first well-performed study of pulmonary
function testing in candidates for lung surgery was
published in 1955 [24], many attempts have been made to
establish criteria to predict postoperative mortality and
cardiopulmonary complications after lung resection. The
criteria used to select patients for major pulmonary resections
are based on clinical data, spirometry, more detailed
pulmonary functional assessment, and cardiac evaluation.
Severe abnormalities detected by spirometry indicate an
increased risk after pulmonary resection and should prompt
further preoperative evaluation and a critical assessment of
the patient’s overall condition [25]. Patients with hypoxemia
or hypercapnia are at increased risk for morbidity or
mortality after thoracotomy [26].  Lung volume
determinations may be helpful, because an increase in the
RV/TLC ratio is associated with a high incidence of
postoperative pulmonary complications [27]. Tests
previously used to evaluate differential function of each
lung, such as bronchospirometry and the lateral position
test, have been replaced by radionuclide lung scanning,
with quantitative measurement of the contribution of each
lung to pulmonary ventilation and blood flow [28]. The
attractive features of radionuclide lung scanning include its
ready availability in general hospitals, negligible risk to
patients, and a fairly high degree of accuracy in the prediction
of postoperative pulmonary function [28]. Pulmonary
hemodynamic measurements may be useful in selected
patients; a right ventricular ejection fraction of at least 35%,
a pulmonary vascular resistance of less than 200 dyne × sec
× cm-5, and a ratio of pulmonary vascular resistance to right
ventricular ejection fraction of less than 5.0 should be
Figure 3. Receiver operating characteristic (ROC) curve of diffusing
capacity for carbon monoxide (DLCO) % predicted for prediction of overall
complications. The solid line is the line of identity for a test without any
discrimination. The area under the ROC curve was 0.84; the best
cut-off point was 70%, with a sensitivity of 62% and specificity of 96%.
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Figure 4. Receiver operating characteristic (ROC) curve of age for
prediction of mortality. The solid line is the line of identity for a test
without any discrimination. The area under the ROC curve was 0.77; the
best cut-off point was 70 years, with a sensitivity of 63% and specificity
of 83%.
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associated with low postpneumonectomy morbidity and
mortality [29]. Exercise testing stresses the entire
cardiopulmonary and oxygen delivery systems and assesses
the reserve that can be expected and may be needed after
surgery [30]. A resting saturation of less than 90% or
desaturation of at least 4% during exercise are significantly
predictive of increased mortality and morbidity [31]. Risk
strat i f i cat ion analys is ,  us ing a  mult i fac tor ia l
cardiopulmonary risk index based on conventional cardiac
and pulmonary clinical data, was highly predictive of
postoperative cardiopulmonary complications [32].
Despite the need for accurate estimation of the risk of
complications after major lung resection, the use of
traditional methods of assessing operative risk provides
only a modest ability to predict postoperative morbidity
and mortality in patients with significant impairment. Newer
tests such as pulmonary hemodynamic measurements are
not widely used because they are expensive and labor
intensive, and few data are available to assess their accuracy.
The recent literature clearly demonstrates that DLCO is an
important predictor of morbidity and mortality [5–8]. DLCO
reflects pulmonary alveolar-capillary surface area and
pulmonary capillary blood volume, provided that it is
corrected for any decrease in hemoglobin content. A low
DLCO indicates the presence of significant emphysematous
changes in the lung [15,16,33] and a reduced pulmonary
capillary bed [16]. The use of DLCO in addition to clinical
data, spirometry, and lung volume assessments will result
in improved prediction of the outcome following lung
resection, especially pneumonectomy.
Untreated lung cancer is a disease with 100% mortality.
Lung resection, the best and potentially curative therapy
for non-small-cell lung cancer, carries risks, especially when
performed on elderly patients with coexistent
cardiopulmonary disease. We advocate the routine use of
diffusing capacity in preoperative assessment prior to lung
resection as an additional test to help identify patients at
increased risk, for whom increased efforts in postoperative
care may help to reduce morbidity and mortality.
Patients whose lung function is below the safe
preoperative limits for lung resection should not be rejected
for surgical therapy, because without surgery, the outlook
for lung cancer is poor. They should be given intensive
therapy to improve lung function. They should also be
counseled as to the risks of death or prolonged disability
from surgery, given other treatment options, and offered
the option of resection using all the postoperative
management skills if the risk for surgery is not considered
prohibitive. However, the previous concept of threshold
values for preoperative variables should be applied
cautiously, especially since lung volume resection surgery
for emphysema [34], applied at the same time as surgery for
lung cancer, may allow patients with marginal lung function,
previously considered inoperable, to undergo lung resection
[35].
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